The purpose of this study is to ascertain whether certain supplements promote excessive
urinary oxalate excretion and increase the risk for calcium oxalate kidney stones.
Supplements that enhance urinary oxalate excretion, as a result of their oxalate
concentration or from some other mechanism (e.g., providing substrate for oxalate
biosynthesis) will be identified by the investigators.
The investigators hypothesize that certain over-the-counter dietary supplements will
increase urinary excretion of oxalate as measured in 24-h urine collections. The
investigators further hypothesize that the concentration of oxalate in dietary supplements
may not be associated with urinary oxalate excretion, suggesting that other nutritional
components of the supplements may be exerting an influence over oxalate biosynthesis,
oxalate absorption in the gastrointestinal tract, and/or renal oxalate handling. These other
factors include the form of oxalate in the supplement (water- vs. non water-soluble) and the
supplement's concentration of ascorbic acid.
- At least 18 years of age, no prior personal history of kidney stones
- Personal history of kidney stones (by subjects' report); known allergy to any of the
dietary supplements to be used in the study (by subjects' report); short bowel;
active ulcerative colitis or irritable bowel disease; Crohns or Celiac disease; renal
tubular acidosis; current use of topiramate or other carbonic anhydrase inhibitor,
steroids, allopurinol, thiazide diuretics, or supplemental ascorbic acid >250 mg/day.
Kristina L Penniston, PhD, RD
Department of Urology, University of Wisconsin School of Medicine and Public Health